5.4.3.8	4,5-Dioxovalerate	competitive inhibition of pyridoxamine-phosphate form of the enzyme and mixed-type inhibition of the pyridoxal-phosphate form of the enzyme	12361	
5.4.3.8	4-Amino-5-fluoro-pentanoic acid	-	91631	
5.4.3.8	4-Amino-5-hexenoic acid	-	91632	
5.4.3.8	4-Amino-5-hexynoic acid	-	43409	
5.4.3.8	Aminooxyacetate	20 mM, 57% inhibition	1374	
5.4.3.8	Aminooxyacetate	-	1374	
5.4.3.8	cycloserine	20 mM, 43% inhibition	2837	
5.4.3.8	D-penicillamine	20 mM, 9% inhibition	2733	
5.4.3.8	gabaculine	0.005 mM, 83% inhibition. Irreversible inhibition which requires the presence of either glutamate-1-semialdehyde or 5-amino-4-oxopentanoate	1869	
5.4.3.8	gabaculine	complete inactivation by gabaculine when the enzyme is exposed to 5-amino-4-oxopentanoate, levulinate or 4,5-dioxovalerate in absence of glutamate 1-semialdehyde	1869